Sudarshan Pharma [SUDARSHAN] vs Styrenix Performance [STYRENIX] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sudarshan Pharma Industries Ltd. wins in 5 metrics, Styrenix Performance Materials Ltd. wins in 13 metrics, with 0 ties. Styrenix Performance Materials Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sudarshan Pharma Industries Ltd. | Styrenix Performance Materials Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 35.73 | 24.75 | Styrenix Performance Materials Ltd. |
| Price-to-Book Ratio | 5.61 | 3.29 | Styrenix Performance Materials Ltd. |
| Debt-to-Equity Ratio | 155.50 | 44.08 | Styrenix Performance Materials Ltd. |
| PEG Ratio | N/A | -0.38 | N/A |
| EV/EBITDA | 20.44 | 18.19 | Styrenix Performance Materials Ltd. |
| Profit Margin (TTM) | 3.26% | 4.66% | Styrenix Performance Materials Ltd. |
| Operating Margin (TTM) | 5.93% | 1.44% | Sudarshan Pharma Industries Ltd. |
| EBITDA Margin (TTM) | 5.93% | 1.44% | Sudarshan Pharma Industries Ltd. |
| Return on Equity | 12.13% | 20.14% | Styrenix Performance Materials Ltd. |
| Return on Assets (TTM) | 3.96% | 10.26% | Styrenix Performance Materials Ltd. |
| Free Cash Flow (TTM) | $304.76M | $-3.82B | Sudarshan Pharma Industries Ltd. |
| Dividend Yield | N/A | 2.80% | N/A |
| 1-Year Return | 19.22% | -27.51% | Sudarshan Pharma Industries Ltd. |
| Price-to-Sales Ratio (TTM) | 1.12 | 1.16 | Sudarshan Pharma Industries Ltd. |
| Enterprise Value | $9.53B | $46.17B | Styrenix Performance Materials Ltd. |
| EV/Revenue Ratio | 1.48 | 1.30 | Styrenix Performance Materials Ltd. |
| Gross Profit Margin (TTM) | 12.03% | 22.15% | Styrenix Performance Materials Ltd. |
| Revenue per Share (TTM) | $26 | $2,019 | Styrenix Performance Materials Ltd. |
| Earnings per Share (Diluted) | $0.84 | $94.19 | Styrenix Performance Materials Ltd. |
| Beta (Stock Volatility) | 0.69 | 0.34 | Styrenix Performance Materials Ltd. |
Sudarshan Pharma Industries Ltd. vs Styrenix Performance Materials Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sudarshan Pharma Industries Ltd. | 0.29% | -6.63% | 10.91% | 32.55% | 30.44% | 27.16% |
| Styrenix Performance Materials Ltd. | -0.93% | -1.65% | -0.61% | 19.11% | 8.02% | 10.05% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sudarshan Pharma Industries Ltd. | 19.22% | 423.13% | 459.90% | 459.90% | 459.90% | 459.90% |
| Styrenix Performance Materials Ltd. | -27.51% | 160.17% | 55.99% | 279.89% | 326.65% | 1,649.71% |
Performance & Financial Health Analysis: Sudarshan Pharma Industries Ltd. vs Styrenix Performance Materials Ltd.
| Metric | SUDARSHAN | STYRENIX |
|---|---|---|
| Market Information | ||
| Market Cap | ₹7.29B | ₹41.02B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 307,600 | 51,222 |
| 90 Day Avg. Volume | 248,667 | 51,528 |
| Last Close | ₹34.47 | ₹2,211.00 |
| 52 Week Range | ₹18.50 - ₹36.95 | ₹1,780.00 - ₹3,498.00 |
| % from 52W High | -6.71% | -36.79% |
| All-Time High | ₹452.70 (Sep 30, 2024) | ₹3,498.00 (Jun 09, 2025) |
| % from All-Time High | -92.39% | -36.79% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.45% | 0.26% |
| Quarterly Earnings Growth | 0.51% | -0.66% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.05% |
| Operating Margin (TTM) | 0.06% | 0.01% |
| Return on Equity (TTM) | 0.12% | 0.20% |
| Debt to Equity (MRQ) | 155.50 | 44.08 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹5.35 | ₹708.41 |
| Cash per Share (MRQ) | ₹0.11 | ₹18.64 |
| Operating Cash Flow (TTM) | ₹8.46M | ₹-3,519,400,000 |
| Levered Free Cash Flow (TTM) | ₹159.55M | ₹2.35B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 2.80% |
| Last 12-Month Dividend | N/A | ₹54.00 |
Valuation & Enterprise Metrics Analysis: Sudarshan Pharma Industries Ltd. vs Styrenix Performance Materials Ltd.
| Metric | SUDARSHAN (Apr 24, 2026) | STYRENIX (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 35.73 | 24.75 |
| Forward P/E | N/A | 19.79 |
| PEG Ratio | N/A | -0.38 |
| Price to Sales (TTM) | 1.12 | 1.16 |
| Price to Book (MRQ) | 5.61 | 3.29 |
| Market Capitalization | ||
| Market Capitalization | ₹7.29B | ₹41.02B |
| Enterprise Value | ₹9.53B | ₹46.17B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.48 | 1.30 |
| Enterprise to EBITDA | 20.44 | 18.19 |
| Risk & Other Metrics | ||
| Beta | 0.69 | 0.34 |
| Book Value per Share (MRQ) | ₹5.35 | ₹708.41 |
Financial Statements Comparison: Sudarshan Pharma Industries Ltd. vs Styrenix Performance Materials Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SUDARSHAN (2025) | STYRENIX (2025) |
|---|---|---|
| Revenue/Sales | 5.05B | 29.82B |
| Cost of Goods Sold | 4.40B | 22.33B |
| COGS % of Revenue | 87.1% | 74.9% |
| Gross Profit | 651.01M | 7.50B |
| Gross Margin | 12.9% | 25.1% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 379.01M | 3.02B |
| Operating Margin | 7.5% | 10.1% |
| EBITDA | 407.72M | 3.55B |
| EBITDA Margin | 8.1% | 11.9% |
| Pre-Tax Income | 216.29M | 3.04B |
| Pre-Tax Income % of Revenue | 4.3% | 10.2% |
| Income Tax | 56.77M | 686.30M |
| Income Tax % of Revenue | 1.1% | 2.3% |
| Net Income (Profit) | 159.53M | 2.35B |
| Profit Margin | 3.2% | 7.9% |
Balance Sheet & Liquidity Metrics
| Metric | SUDARSHAN (2025) | STYRENIX (2025) |
|---|---|---|
| Cash & Equivalents | 5.51M | 976.50M |
| Total Current Assets | 3.35B | 13.61B |
| Total Current Assets % of Revenue | 66.3% | 45.6% |
| Total Current Liabilities | 2.60B | 6.61B |
| Total Current Liabilities % of Revenue | 51.4% | 22.1% |
| Long-Term Debt | 104.60M | 3.77B |
| Long-Term Debt % of Revenue | 2.1% | 12.6% |
| Total Shareholders Equity | 1.31B | 11.68B |
| Retained Earnings | N/A | 7.40B |
| Retained Earnings % of Revenue | 0.0% | 24.8% |
| Property, Plant & Equipment | 200.50M | 8.53B |
Cash Flow Statement Comparison
| Metric | SUDARSHAN (2025) | STYRENIX (2025) |
|---|---|---|
| Operating Cash Flow | 8.46M | -3.52B |
| Operating Cash Flow % of Revenue | 0.2% | -11.8% |
| Capital Expenditures | -47.46M | -4.36B |
| Free Cash Flow | 304.76M | -3.82B |
| FCF Margin | 6.0% | -12.8% |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SUDARSHAN | STYRENIX |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 240.66M | 17.59M |
| Float Shares | 87.72M | 8.96M |
| % Held by Insiders | 76.52% | 48.50% |
| % Held by Institutions | 0.00% | 15.59% |
| % Held by Public | 23.48% | 35.91% |
Dividend Analysis & Yield Comparison: Sudarshan Pharma Industries Ltd. vs Styrenix Performance Materials Ltd.
| Metric | SUDARSHAN | STYRENIX |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹54.00 |
| Last 12-Month Dividend Yield | N/A | 2.80% |
| 3-Year Avg Annual Dividend | N/A | ₹95.67 |
| 3-Year Avg Dividend Yield | N/A | 2.83% |
| 3-Year Total Dividends | N/A | ₹287.00 |
| Ex-Dividend Date | N/A | Feb 05, 2026 |